|
Neurology
|
|
|
LONDON – Sertraline and mirtazapine, two commonly prescribed antidepressants shown to carry risks of adverse events in dementia patients, had no more clinical benefit than placebo in people with possible or probable Alzheimer’s disease, a multicenter trial in the United Kingdom found. ... »
Atrial Fibrillation Boosted Fall Risk in Elderly Patients
SAN FRANCISCO – A history of atrial fibrillation more than tripled the risk of a nonaccidental fall in elderly people, an emergency department study showed.
Of 459 consecutive elderly patients who presented to a large emergency department with a chief complaint of a fall, 225 had a fall deemed to... » Subthalamic nucleus deep brain stimulation doesn’t appear to change the course of Parkinson’s disease when it is performed on patients with long-standing disease.
In the longest follow-up cohort study to date, Aristide Merola, MD, and his colleagues tracked patients who underwent the procedure at... » Subthalamic nucleus deep brain stimulation doesn’t appear to change the course of Parkinson’s disease when it is performed on patients with long-standing disease.
In the longest follow-up cohort study to date, Aristide Merola, MD, and his colleagues tracked patients who underwent the procedure at... » Atypical antipsychotics are effective in only a few of the many off-label conditions for which they are currently used, according to a meta-analysis published in JAMA.
In particular, there is no good evidence to support the use of atypical antipsychotics for substance abuse disorder, eating... »
Brain Stimulation Didn't Alter Course of Parkinson's Disease
Brain Stimulation Didn't Alter Course of Parkinson's Disease
AHRQ Study of Antipsychotic Use: Mixed
AMDA is the only national organization guided exclusively by the needs and issues affecting long term care medicine. For a full array of benefits and services exclusively for LTC professionals, click here to join today!